D. G. Soares

发表

A rational approach for salvage of testicular cancer patients.

F. Selle, D. G. Soares, J. Lotz, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Influence of irofulven, a transcription-coupled repair-specific antitumor agent, on RNA polymerase activity, stability and dynamics in living mammalian cells

A. Escargueil, P. Cook, A. Sarasin, 2008, Journal of Cell Science.

The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.

A. Escargueil, A. Sarasin, J. Henriques, 2010, Biochemical pharmacology.

PARPs and the DNA damage response.

A. Escargueil, F. Sousa, J. Henriques, 2012, Carcinogenesis.

Low cytotoxicity of ecteinascidin 743 in yeast lacking the major endonucleolytic enzymes of base and nucleotide excision repair pathways.

D. Bonatto, J. Henriques, D. G. Soares, 2005, Biochemical pharmacology.

DNA repair pathways involved in repair of lesions induced by 5-fluorouracil and its active metabolite FdUMP.

A. Escargueil, F. Sousa, I. Grivicich, 2010, Biochemical pharmacology.

Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study.

I. Ray-Coquard, F. Goldwasser, O. Trédan, 2016, Oncology letters.

Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems.

D. G. Soares, A. Andreazza, M. Salvador, 2003, Journal of agricultural and food chemistry.

Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair

A. Escargueil, C. Galmarini, J. Henriques, 2016, Oncotarget.

DNA alkylation damage and autophagy induction.

A. Escargueil, L. Meira, G. Lenz, 2013, Mutation research.

Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743

A. Escargueil, D. Bonatto, A. Sarasin, 2007, Proceedings of the National Academy of Sciences.

BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder

A. Escargueil, J. Henriques, D. G. Soares, 2015, Cell cycle.

Ataxia telangiectasia mutated- and Rad3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S23906.

A. Escargueil, J. Henriques, D. G. Soares, 2011, The Biochemical journal.

Ataxia telangiectasia mutated-and Rad 3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S 23906

A. Escargueil, J. Henriques, D. G. Soares, 2011 .

Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer Patient

D. G. Soares, J. Lotz, F. Millot, 2016, Urology case reports.

What histone code for DNA repair?

A. Escargueil, J. Henriques, D. G. Soares, 2008, Mutation research.

A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study

P. Viens, J. Gligorov, S. Richard, 2015, Chemotherapy.

Pertuzumab and trastuzumab: the rationale way to synergy.

J. Gligorov, S. Richard, F. Selle, 2016, Anais da Academia Brasileira de Ciencias.

The DNA damage response to monofunctional anticancer DNA binders

A. Escargueil, D. G. Soares, A. Larsen, 2012 .

Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells

A. Escargueil, C. Galmarini, A. Sarasin, 2011, Molecular Cancer Therapeutics.

Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso)

A. Dem, D. G. Soares, J. Lotz, 2018, World Journal of Surgical Oncology.

ATP-dependent chromatin remodeling and histone acetyltransferases in 5-FU cytotoxicity in Saccharomyces cerevisiae.

A. Escargueil, D. Bonatto, F. Sousa, 2013, Genetics and molecular research : GMR.

Saccharomyces cerevisiae as a model system to study the response to anticancer agents

A. Escargueil, D. Bonatto, F. Sousa, 2012, Cancer Chemotherapy and Pharmacology.

Preclinical Development Trabectedin and Its C Subunit Modified Analogue PM 01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells

A. Escargueil, C. Galmarini, A. Sarasin, 2011 .

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer

J. Gligorov, S. Richard, F. Selle, 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.

B. Bui, P. Biron, J. Bay, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Trabectedin for sarcomas in daily clinical practice: analysis of 45 patients treated in a French institution

D. G. Soares, J. Lotz, I. Debrix, 2016, Journal of chemotherapy.

Pertuzumab and trastuzumab: the rationale way to synergy.

J. Gligorov, S. Richard, F. Selle, 2016, Anais da Academia Brasileira de Ciencias.

B. Bui, P. Biron, J. Bay, 2014 .